BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
BioXcel Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
BioXcel Therapeutics reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at BioXcel Therapeutics received on average a compensation package of $2.4M, a 8% decrease compared to previous year.
Average pay of disclosed executives at BioXcel Therapeutics
Vimal Mehta, Chief Executive Officer, received $4.7M in total, which increased by 4% compared to 2022. 55% of Mehta's compensation, or $2.6M, was in option awards. Mehta also received $1M in salary, $1.1M in stock awards, as well as $16K in other compensation.
Matthew Wiley, SVP and Chief Commercial Officer, received a compensation package of $1.3M, which decreased by 34% compared to previous year. 44% of the compensation package, or $561K, was in option awards.
Javier Rodriguez, Chief Legal Officer, earned $1.1M in 2023, a 8% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.